中国医学装备Issue(12)：136-138,139,4.DOI:10.3969/J.ISSN.1672-8270.2014.12.051
重组人组织型纤溶酶原激活剂溶栓治疗高龄脑梗死患者的临床价值
Research on effect of rt-PA thrombolytic therapy on elderly patients with cerebral infarction
周霞 1张诚2
作者信息
- 1. 自贡市第三人民医院神经内科 四川 自贡 643020
- 2. 四川大学华西医院神经外科 四川 成都 610041
- 折叠
摘要
Abstract
Objective: To analyze the Effect of rt-PA thrombolytic therapy on elderly patients with cerebral infarction. Methods: Chosen elderly patients with cerebral infarction between November 2012 to November 2013 as study object, randomly divided into observe group receive rt-PA thrombolytic therapy and control group receive aspirin and Batroxobin, detecting neurological impairment, physical function score and adverse treatment outcomes. Results: 1)before thrombolytic treatment, neurological deficit situation of two groups were no significant difference (P>0.05), after treatment, observation group patients’ neurological deficit scores were significantly lower than control group at each time point (P<0.05); 2)after treatment, limb function defective number of observation group patient was significantly less than observation group(P<0.05); 3)after treatment, observation groups’ adverse outcomes as again infarction, large area cerebral hemorrhage after thrombolysis, plant survival, incidence of death was significantly lower than control group (P<0.05). Conclusion: The injection of rt-PA thrombolytic therapy can significantly optimize neurological and physical function in patients , reducing the incidence of adverse treatment outcomes, with positive clinical significance.关键词
脑梗死/重组人组织型纤溶酶原激活剂/溶栓/高龄Key words
Infarction/Recombinant tissue plasminogen activator/Thrombolysis/Advanced age分类
医药卫生引用本文复制引用
周霞,张诚..重组人组织型纤溶酶原激活剂溶栓治疗高龄脑梗死患者的临床价值[J].中国医学装备,2014,(12):136-138,139,4.
